Compare LUNG & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNG | DFLI |
|---|---|---|
| Founded | 1995 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 49.0M |
| IPO Year | 2020 | N/A |
| Metric | LUNG | DFLI |
|---|---|---|
| Price | $1.27 | $2.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $5.38 | $3.25 |
| AVG Volume (30 Days) | 298.4K | ★ 378.4K |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,497,000.00 | N/A |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | $51.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $0.15 |
| 52 Week High | $5.46 | $5.15 |
| Indicator | LUNG | DFLI |
|---|---|---|
| Relative Strength Index (RSI) | 40.15 | 48.28 |
| Support Level | $1.13 | $1.56 |
| Resistance Level | $1.64 | $2.24 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 10.79 | 49.98 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.